However, in lung adenocarcinoma (LUAD), the relationship between the expression level of DNMT3a and clinical prognosis remains to be explored, and the molecular mechanism by which DNMT3a mediates malignant tumour progression remains unclear. Here, DNMT3A is linked to lung adenocarcinoma.